Literature DB >> 3347414

Evaluation and management of the pelvic mass: a review of 540 cases.

M A Killackey1, R S Neuwirth.   

Abstract

The management of 540 patients with the diagnoses of "pelvic mass/uterine leiomyomata" was reviewed with respect to preoperative evaluation, surgical procedures, and final pathologic diagnosis. Approximately 6170 patients were admitted to the Gynecology Service at St. Luke's-Roosevelt Hospital Center from July 1984 to June 1985. During this period, 36 of 432 diagnostic laparoscopies (8.3%) and 503 of 1666 laparotomies (30.2%) were performed to evaluate or treat these women. The final diagnoses in the 249 patients admitted with the impression of leiomyomata were: leiomyomata, 235 (94.4%); benign adnexal masses, seven (2.8%); cancers, four (1.6%); and miscellaneous, three (1.2%). Of the 291 patients evaluated for pelvic mass, the findings were: benign ovarian or tubal cysts, 98 (33.7%); leiomyomata, 42 (14.4%); cancers, 40 (13.7%); benign cystic teratomas, 38 (13.1%); endometriosis, 28 (9.6%); miscellaneous, 23 (7.9%); and pelvic inflammatory disease, 22 (7.6%). Correlation between the patient's age, preoperative impression, and final diagnosis is presented with particular attention to the 44 patients (8.1%) in whom malignancy was found. All the possibilities that such masses may represent must be considered preoperatively, and the patient be informed of her risk of malignancy.

Entities:  

Mesh:

Year:  1988        PMID: 3347414

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial.

Authors:  Sarah J Nyante; Amanda Black; Aimée R Kreimer; Máire A Duggan; J Daniel Carreon; Bruce Kessel; Saundra S Buys; Lawrence R Ragard; Karen A Johnson; Barbara K Dunn; Lois Lamerato; John M Commins; Christine D Berg; Mark E Sherman
Journal:  Gynecol Oncol       Date:  2010-12-07       Impact factor: 5.482

Review 2.  Ovarian tumor-derived ectopic hyperprolactinemia.

Authors:  Autumn F Elms; S J Carlan; Amy E Rich; Lizardo Cerezo
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

3.  Inflammatory markers in women with reported benign gynecologic pathology: an analysis of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Authors:  Lauren A King; Nicolas Wentzensen; Mark P Purdue; Hormuzd A Katki; Ligia A Pinto; Britton Trabert
Journal:  Ann Epidemiol       Date:  2021-12-11       Impact factor: 3.797

Review 4.  The Value of Ultrasound Monitoring of Adnexal Masses for Early Detection of Ovarian Cancer.

Authors:  Elizabeth Suh-Burgmann; Walter Kinney
Journal:  Front Oncol       Date:  2016-02-10       Impact factor: 6.244

5.  Measurement of phospholipids may improve diagnostic accuracy in ovarian cancer.

Authors:  Lian Shan; Y Ann Chen; Lorelei Davis; Gang Han; Weiwei Zhu; Ashley D Molina; Hector Arango; James P LaPolla; Mitchell S Hoffman; Thomas Sellers; Tyler Kirby; Santo V Nicosia; Rebecca Sutphen
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.